‹ PHAT latest research

PHAT (Phathom Pharmaceuticals, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed PHAT on 3 market nights between October 30, 2026 and November 3, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

3 calls 0 BUY · 3 HOLD · 0 SELL
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
November 3, 2026 HOLD $5.91 — / — not yet not yet
The current market and stock conditions do not support a BUY recommendation.
November 2, 2026 HOLD $5.74 — / — not yet not yet
The stock's high volatility and current technical weakness necessitate a cautious approach, waiting for clearer signals.
October 30, 2026 HOLD $6.22 $7.02 / $5.29 not yet not yet
The stock is currently at a key resistance level, and the technicals are neutral to bearish, suggesting a short-term pullback is more likely than a sustained rally.

Related stocks

XERS Xeris Biopharma Holdings, InSNDX Syndax Pharmaceuticals, Inc.SGRY Surgery Partners, Inc.RXRX Recursion Pharmaceuticals, IREPL Replimune Group, Inc.PFE Pfizer, Inc.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated November 4, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.